Royce & Associates’s Aehr Test Systems AEHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.41M | Sell |
38,102
-4,000
| -10% | -$128K | 0.01% | 625 |
|
|
2025
Q4 | $850K | Sell |
42,102
-13,323
| -24% | -$322K | 0.01% | 672 |
|
|
2025
Q3 | $1.67M | Sell |
55,425
-56,123
| -50% | -$1.22M | 0.02% | 608 |
|
|
2025
Q2 | $1.44M | Sell |
111,548
-60,217
| -35% | -$573K | 0.01% | 639 |
|
|
2025
Q1 | $1.25M | Hold |
171,765
| – | – | 0.01% | 648 |
|
|
2024
Q4 | $2.86M | Hold |
171,765
| – | – | 0.03% | 573 |
|
|
2024
Q3 | $2.21M | Hold |
171,765
| – | – | 0.02% | 608 |
|
|
2024
Q2 | $1.92M | Buy |
171,765
+10,000
| +6% | +$117K | 0.02% | 621 |
|
|
2024
Q1 | $2.01M | Buy |
161,765
+56,500
| +54% | +$942K | 0.02% | 631 |
|
|
2023
Q4 | $2.79M | Sell |
105,265
-87,100
| -45% | -$2.54M | 0.03% | 601 |
|
|
2023
Q3 | $8.79M | Sell |
192,365
-82,594
| -30% | -$3.83M | 0.09% | 327 |
|
|
2023
Q2 | $11.3M | Buy |
274,959
+34,700
| +14% | +$1.14M | 0.11% | 279 |
|
|
2023
Q1 | $7.45M | Sell |
240,259
-134,100
| -36% | -$4.32M | 0.07% | 388 |
|
|
2022
Q4 | $7.52M | Buy |
374,359
+144,800
| +63% | +$3.1M | 0.08% | 368 |
|
|
2022
Q3 | $3.24M | Sell |
229,559
-50,000
| -18% | -$673K | 0.04% | 548 |
|
|
2022
Q2 | $2.1M | Sell |
279,559
-30,900
| -10% | -$257K | 0.02% | 656 |
|
|
2022
Q1 | $3.15M | Buy |
310,459
+48,800
| +19% | +$624K | 0.03% | 644 |
|
|
2021
Q4 | $6.33M | Sell |
261,659
-242,100
| -48% | -$4.73M | 0.05% | 507 |
|
|
2021
Q3 | $6.88M | Sell |
503,759
-544,141
| -52% | -$3.91M | 0.05% | 521 |
|
|
2021
Q2 | $2.89M | Hold |
1,047,900
| – | – | 0.02% | 700 |
|
|
2021
Q1 | $2.64M | Hold |
1,047,900
| – | – | 0.02% | 708 |
|
|
2020
Q4 | $2.65M | Sell |
1,047,900
-246,000
| -19% | -$411K | 0.02% | 677 |
|
|
2020
Q3 | $1.8M | Hold |
1,293,900
| – | – | 0.02% | 698 |
|
|
2020
Q2 | $2.52M | Hold |
1,293,900
| – | – | 0.03% | 621 |
|
|
2020
Q1 | $2.16M | Buy |
1,293,900
+52,200
| +4% | +$101K | 0.03% | 573 |
|
|
2019
Q4 | $2.48M | Hold |
1,241,700
| – | – | 0.02% | 658 |
|
|
2019
Q3 | $2.22M | Hold |
1,241,700
| – | – | 0.02% | 685 |
|
|
2019
Q2 | $2.05M | Hold |
1,241,700
| – | – | 0.02% | 715 |
|
|
2019
Q1 | $1.71M | Hold |
1,241,700
| – | – | 0.01% | 777 |
|
|
2018
Q4 | $1.75M | Buy |
1,241,700
+151,400
| +14% | +$283K | 0.02% | 770 |
|
|
2018
Q3 | $2.42M | Buy |
1,090,300
+643,500
| +144% | +$1.59M | 0.02% | 791 |
|
|
2018
Q2 | $1.05M | Buy |
446,800
+141,800
| +46% | +$350K | 0.01% | 934 |
|
|
2018
Q1 | $686K | Hold |
305,000
| – | – | ﹤0.01% | 1021 |
|
|
2017
Q4 | $827K | Hold |
305,000
| – | – | 0.01% | 1000 |
|
|
2017
Q3 | $1.25M | Buy |
305,000
+20,000
| +7% | +$71.7K | 0.01% | 910 |
|
|
2017
Q2 | $1.07M | Buy |
+285,000
| New | +$1.2M | 0.01% | 956 |
|
Other funds holding AEHR
AIC
VCM
VPM
NCGI
Royce & Associates's AEHR Position: Q1 2026 in Review
Royce & Associates reduced its Aehr Test Systems (AEHR) stake by 9.5% in Q1 2026, selling an estimated $128K and leaving 38,102 shares worth $1.41M. The position accounts for 0.01% of the portfolio, ranked #625.
Royce & Associates first reported a position in AEHR in Q2 2017 and has held it in 36 quarters since. The position peaked at $11.3M in Q2 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.
- Royce & Associates held 38,102 shares of Aehr Test Systems worth $1.41M as of Q1 2026.
- Royce & Associates sold 4,000 Aehr Test Systems shares in Q1 2026, an estimated $128K.
- Aehr Test Systems made up 0.01% of Royce & Associates's portfolio in Q1 2026, its #625 holding.
- Royce & Associates first reported a position in Aehr Test Systems in Q2 2017 and has held it in 36 quarters since.
- Royce & Associates's Aehr Test Systems position peaked at $11.3M in Q2 2023.
- 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.
Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.